Orange Biomed

At #CES2025, health tech innovators showcased the technology advancements that are addressing the current challenges in healthcare, including AI-powered diagnostics and at-home health tech solutions. In the months following CES, we have seen how these advancements are steadily gaining traction and shaping industry trends forward. Orange Biomed shares key takeaways in our recent article featuring industry insights and current market shifts: “CES Health Tech 2025: Innovation, Challenges, and the Future of Digital Health” – bit.ly/41LiESv As a global epicenter of innovation, the event provided the opportunity to learn about fellow chronic disease digital health solutions that are shifting care and prevention into the hands of patients from trailblazers such as OnMed and Withings. CES 2025 also highlighted a noticeable gap between established health tech brands and startups. While major companies consistently drive innovation, smaller startups introduce groundbreaking ideas but often get left behind due to the steep costs of commercialization. However, the future lies in building strategic partnerships with innovators like Orange Biomed that are making breakthrough advancements in #microfluidic technology, and capitalizing on South Korea’s leadership in AI and #microelectronics. Read the full article for the latest health tech industry trends from CES 2025 and beyond: bit.ly/41LiESv #Healthcare #Research #Patients #DiabetesTesting #A1C #HbA1c #DiabetesInnovation #HealthcareTechnology

Happy #InternationalWomensDay! At Orange Biomed, we champion equal and inclusive opportunities for women in science and encourage women to pursue innovation and lead groundbreaking change in the field. Today, we highlight four women on our team who are dedicated to advancing diabetes and creating more equitable opportunities: Yeaseul Park - CEO, Co-Founder Eunyoung Park - Chief Research Officer, Co-Founder You-ra Park - Key Contributor? ??? Goeun Kim - Key Contributor Meet our Leadership Team here: bit.ly/4hPZBMd In recognition of International Women’s Day and Orange Biomed’s mission to reduce healthcare disparities, register for the International Diabetes Federation’s Webinar: “Women with Diabetes: Navigating Life’s Stages & Driving Advocacy” happening March 7th, 7:00?AM Friday ET (1:00?PM Friday CET). The event unites women committed to raising diabetes awareness to share their stories, discuss current healthcare challenges, and empower women to advocate for improved support, care, and policies globally. Attendees will hear from featured speakers Phyllisa Deroze, PhD, Dr. Hermelinda Pedrosa, Anita Sabidi, and Dawn Adams. Learn more here: bit.ly/3Xjfxi2 #IWD #IWD2025 #AccelerateAction #GenderEquality #IDF #Diabetes #DiabetesCare #HealthEquality #WomenLeaders?

In celebration of #BlackHistoryMonth, Orange Biomed spoke with Wanya Reese of Denver7 (KMGH-TV) to share our solution for overcoming disparities Black people face when testing A1C. Multiple studies show that Black people are facing struggles of getting inaccurate A1C readings. Health disparities have impacted the Black population for decades in the U.S. This live TV segment highlights Dr. Terri Richardson from the COLORADO BLACK HEALTH COLLABORATIVE who shared, "Everybody knows about Henrietta Lacks and Tuskegee, those were specifically things in our history that occurred. It's not fiction. Tuskegee went on from 1932 to 1972, where Black men with syphilis were not treated, even when it was available.” At Orange Biomed, we focus on making healthcare monitoring easier and more accessible for all populations. “We wanted to empower people to take charge of their own health, giving them accurate, convenient and reliable tools so that they can take care of their health on their own terms," Co-founder Young Chan (Luke) Jo said. This led us to develop our groundbreaking solution: OBM rapid A1c, that provides more accurate A1C readings by eliminating interferences derived from differences in hemoglobins in different races. "We wanted to provide a better solution that can be just used at their home. So this small device [is] just like glucose meter, self-glucose meters, so that you can check your condition whenever you want," said Yeaseul Park, CEO and Co-President of Orange Biomed. Watch our full feature on Denver 7 news to learn more about the challenges Black Americans face in receiving accurate readings: bit.ly/3XuwFS7 #Diabetes #DiabetesCare #Healthcare #DiabetesAwareness #DiabetesResearch #DiabetesPatients #DiabetesTesting #A1C #HbA1c #DiabetesInnovation #HealthcareTechnology #FutureOfHealthcare #Healthequality?

“The AADA aims to dismantle barriers to equitable diabetes care, amplify Black voices, and advocate for policies that address social determinants of health. Our goal is to educate communities, eradicate racial inequalities in diabetes care, and empower Black individuals to live healthier lives” shared Leon Rock, African American Diabetes Association Co-Founder, in the February edition of our Diabetes Dispatch newsletter. As #BlackHistoryMonth concludes, learn more about the challenges in diabetes care Black people face in our newsletter below. #Diabetes #DiabetesCare #Healthequality #AADA #AfricanAmericanDiabetesAssociation?

As we celebrate #NationalWomenInventorsMonth, Orange Biomed honors the women who were pivotal in understanding the development of diabetes and treatment methods. In 1964, Dr. Dorothy Crowfoot Hodgkin won the Nobel Prize in Chemistry for solving the atomic structure for penicillin and vitamin B12. Dr. Hodgkin later would dedicate her time to developing X-ray crystallography and computing techniques that would solve the structure of insulin. Today, we recognize her impact in diabetes treatment by enabling mass production and allowing scientists to modify the structure of insulin to improve drug options. See the full list of Nobel Prize Winning Women Inventors in JDRF International's latest article: bit.ly/3QeOfW9 Orange Biomed is proud to have two female leaders: Yeaseul Park, CEO & Co-Founder and Eunyoung Park, CRO & Co-Founder, who are continuing Dr. Hodgkin's legacy by transforming diabetes care through our breakthrough OBM rapid A1c solution that is advancing microfluidic technology by performing single-cell analysis for rapid, lab-accurate results for all. Learn more about the OBM rapid A1c:bit.ly/4hwSAQs #diabetes #diabetescare #healthcare #diabetesawareness #diabetesresearch #womeninstem #healthcarebreakthrough #healthresearch?

In honor of #BlackHistoryMonth, Orange Biomed is shining a light on the diabetes disparities within the Black community. We encourage diabetes educators to acknowledge and address the connection between race, socioeconomic status, and health. Social determinants of health impact the prevalence, management, and overall outcomes of diabetes among Black Americans. Compared to their white counterparts, Black Americans are 60% more likely to be diagnosed with diabetes and are at an increased risk of developing diabetes complications such as heart disease, stroke, kidney disease, and lower extremity amputations. Diabetes Education Services is working to raise awareness for “Diabetes Disparities in the Black Community” and highlighting the need for culturally relevant healthcare to be accessible to Black Americans. A lack of inclusive healthcare environments within Black communities leads to lower rates of physician visits, medication adherence, and preventive care. To close these gaps in healthcare, Diabetes Education Services emphasizes the need for community-based interventions, healthcare system reforms, policy changes, and targeted public health initiatives. To stay educated on the health care disparities in the U.S., visit the Diabetes Education Services’ Black History Month blog and check out their resources to make a change: bit.ly/42FGMGU #diabetes #diabetescare #healthcare #diabetesawareness #diabetesresearch #healthinequality #healthdisparities #racialinqualities #healthequality?

How can the OBM rapid A1c advance current monitoring systems? Find out in our media feature by jihoon park: bit.ly/4hEvqqV Orange Biomed Co-Founders Yeaseul Park and Unghyeon Ko are featured in Ji-hoon Park's article that highlights how we aim to make measuring HbA1c easy and accurate for anyone by overcoming current challenges such as limited patient accessibility, complex processing, refrigerated distribution and storage of reagents, and the amount of staff needed to measure accurate blood volume. OBM rapid A1c uses microfluidics technology to quickly and accurately measure glycated hemoglobin levels without any reagent preparation or complicated management. With the solution, patients can receive accurate test results from a minimal blood sample, without the need for device maintenance. In 2025, Orange Biomed is recruiting experts in licensing, strategy, and marketing, as well as PhD-level researchers to support global expansion, drive global sales, and enhance brand value. “We will open an era in which the 500 million people with diabetes around the world can use accurate glycated hemoglobin measurements to reduce their fears in preventing complications,” shared CEO Yeaseul Park. Read the full media feature to learn more about our technology and future plans: bit.ly/4hEvqqV #Diabetes #DiabetesCare #Healthcare #DiabetesAwareness #DiabetesResearch #DiabetesPatients #DiabetesTesting #CGM #A1C #HbA1c #DiabetesInnovation #HealthcareTechnology #FutureOfHealthcare

Happy Lunar New Year from the Orange Biomed team! As we reflect on the past year, we are honored to have gained invaluable experiences, connected with industry leaders, exchanged insights with other innovators, and achieved tremendous milestones. In this past year, Orange Biomed participated in various industry events and trade shows, such as the American Diabetes Association’s 2024 Scientific Sessions, MEDICA’s 2024 Conference, the COMEUP (??) Global Startup Festival, and more, with highlights below. Most recently, the Orange Biomed team attended #CES2025 in Las Vegas, where You-ra Park and Sangwoo Kim presented OBM rapid A1c. They showcased how our breakthrough microfluidic-based technology application performs single-cell analysis for rapid, lab-accurate results and is poised to transform the future of healthcare. We were thrilled to connect with fellow industry pioneers, including Becker Hao, TaeHwan Kim, Jaeyoung Kim, Carl Wong, Harry JUNG, and Jerry Nakafuji. One highlight from our 2024 event attendance was the Annual Diabetes Technology Meeting, hosted by the Diabetes Technology Society (DTS), where we were selected for the Startup Showcase and connected with other diabetes advocates and innovators David Klonoff, Jane Jeffrie Seley DNP MPH MSN GNP BC-ADM CDCES, Joe Wang, Stefan Pleus, Muhannad Alkilani, Guido Freckmann, Irina Nayberg, and more. Check out our blog to see our #DTM2024 takeaways: bit.ly/3CjIC5G Orange Biomed was grateful to have been recognized for our work by various organizations this year. At the KHF - HIMSS 24 APAC conference, Orange Biomed was honored with the prestigious KHF Innovation Award for OBM rapid A1c. We were also recognized for our achievements and named a Rocket League company at the 2024 COMEUP (??) Global Startup festival: bit.ly/4hmOzxx Orange Biomed engaged with audiences through various publications over the year. During #DiabetesAwarenessMonth in November, our Co-Founders Yeaseul Park and Dr. Unghyeon Ko were featured in BioSpectrum Asia’s #WorldDiabetesDay report, which highlighted OBM rapid A1c as a digital innovation advancing diabetes care: bit.ly/4fWBnhY Also in November, Orange Biomed Co-Founder Yeaseul Park spoke with Scott Jacobsen of The Good Men Project about the limitations of current A1C testing, specifically how traditional A1C tests can produce inaccurate A1C readings due to hemoglobin variants, which OBM rapid A1c avoids. Check out the full interview here: bit.ly/3Vlp72I Ahead of our #CES attendance, ET News interviewed Yeaseul Park to discuss the status and future of our solution in the U.S. market. Read more: bit.ly/4h2tBUM and see our most recent media mentions here: https://lnkd.in/gpbPJCwM The Orange Biomed team is grateful for the opportunities, connections, and achievements this year brought and we are looking forward to a fantastic #NewYear! #DiabetesInnovation #DiabetesCare #DiabetesAwareness #HealthcareTechnology #FutureOfHealthcare

January was a milestone-filled month! At #CES2025, we proudly presented our cutting-edge technology alongside healthcare innovators like Tuya Smart, Sky Labs Inc., LaMeditech, and more to explore collaborations to solve industry challenges and improve patient outcomes Stay up to date with the latest in #DiabetesNews with our first 2025 edition of Diabetes Dispatch. #Diabetes #Innovation #A1C #HealthcareTech #Newsletter

As we continue to honor #MLKJr for his ever-lasting impact on equality, Orange Biomed recognizes the challenges many Black Americans still face in receiving proper healthcare. The disproportionate impact of health issues is driven by gaps in healthcare, socioeconomic inequalities, and systemic racism. In the U.S., Black adults are 60% more likely to be diagnosed with diabetes and twice as likely to die from it compared to White adults. They're also 3x more likely to be hospitalized for diabetes-related issues and 2x more likely to undergo leg or foot amputations. To combat this, the African American Diabetes Association (AADA) is leading public health initiatives to provide increased support for Black Americans with diabetes. Cofounded by #DiabetesAdvocate Barbara King, M.ED, DVC, CFS, the organization empowers communities affected by healthcare disparities, striving for health equity for all. Find out how you can join the #AADA in the fight for health equality: bit.ly/3oHn77Z #MLKDay #diabetes #diabetescare #healthcare #diabetesawareness #diabetesresearch #healthinequality #AfricanAmericanDiabetesAssociation #healthdisparities #MartinLutherKing #MartinLutherKingJr #MLK?